Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Emeritus Professor Eric Espiner

Eric EspinerMB ChB MD(Otago) FRACP FRSNZ

Email eric.espiner@otago.ac.nz

Christchurch Heart Institute
Department of Medicine
University of Otago, Christchurch
PO Box 4345
Christchurch 8140
New Zealand

Current Roles

  • Emeritus Professor

Research Interests

  • Natriuretic Peptides
  • C-type Natriuetic Peptide regulation and roles in cardiovascular disorders, fetal and maternal welfare, and linear growth.

^ Top of page

Publications

Madhavan, S., Prickett, T. C. R., Espiner, E. A., & Barrell, G. K. (2017). Nutrient restriction in early ovine pregnancy stimulates C-type natriuretic peptide production. Reproduction, Fertility & Development, 29(3), 575-584. doi: 10.1071/RD15192

Wilson, M. O., McNeill, B. A., Barrell, G. K., Prickett, T. C. R., & Espiner, E. A. (2017). Dexamethasone increases production of C-type natriuretic peptide in the sheep brain. Journal of Endocrinology. Advance online publication. doi: 10.1530/joe-17-0148

Woodward, Z., Prickett, T. C. R., Espiner, E. A., & Anderson, T. J. (2017). Central and systemic C-type Natriuretic Peptide are both reduced in Parkinson's Disease. Parkinsonism & Related Disorders. Advance online publication. doi: 10.1016/j.parkreldis.2017.06.019

Prickett, T. C. R., Doughty, R. N., Troughton, R. W., Frampton, C. M., Whalley, G. A., Ellis, C. J., Espiner, E. A., & Richards, A. M. (2017). C-type natriuretic peptides in coronary disease. Clinical Chemistry, 63(1), 316-324. doi: 10.1373/clinchem.2016.257816

Olney, R. C., Salehi, P., Prickett, T. C. R., Lima, J. J., Espiner, E. A., Sikes, K. M., & Geffner, M. E. (2016). Dynamic response of C-type natriuretic peptide and its aminoterminal propeptide (NTproCNP) to growth hormone treatment in children with short stature. Clinical Endocrinology, 85(4), 561-568. doi: 10.1111/cen.13103

Chapter in Book - Research

Prickett, T. C. R., & Espiner, E. A. (2012). C-type natriuretic peptide (CNP) and postnatal linear growth. In V. R. Preedy (Ed.), Handbook of growth and growth monitoring in health and disease. (pp. 2789-2809). New York: Springer. doi: 10.1007/978-1-4419-1795-9

Rademaker, M. T., & Espiner, E. A. (2002). Cardiovascular hormones. In G. M. Besser & M. O. Thorner (Eds.), Comprehensive Clinical Endocrinology. (3rd ed.) (pp. 485-499). Edinburgh: Mosby.

Rademaker, M. T., & Espiner, E. A. (2001). The endrocrine heart. In K. Becker (Ed.), Principles and Practice of Endocrinology and Metabolism (3rd edition). (pp. 1622-1634). Philadelphia: Lippincott Williams and Wilkins.

Rademaker, M. T., & Espiner, E. A. (2001). Hormones of the cardiovascular system. In L. J. DeGroot & J. L. Jameson (Eds.), Endocrinology. (4th ed.) (pp. 1791-1809). Philadelphia: W. B. Saunders Company.

Espiner, E. A., Richards, A. M., & Nicholls, M. G. (1998). Physiology of natriuretic peptides. In E. R. Levin & J. Nadler (Eds.), Endocrinology of Cardiovascular Function. Kluwer Academic Publishers.

Espiner, E. A. (1997). Physiology of natriuretic peptides. In W. K. Samson & E. R. Levin (Eds.), Natriuretic Peptides in Health and Disease. (Contemporary Endocrinology, 5). (pp. 123-146). Totowa, N.J.: Humana Press.

^ Top of page

Chapter in Book - Other

Richards, M., Troughton, R., Espiner, E., Cameron, V., Ellmers, L., Pilbrow, A., Charles, C., Rademaker, M., Pemberton, C., & Yandle, T. (2013). Christchurch Heart Institute. In P. Joyce, G. Nicholls, K. Thomas & T. Wilkinson (Eds.), The Christchurch experience: 40 years of research and teaching. (pp. 68-74). Christchurch, New Zealand: University of Otago.

Espiner, E. (2013). Medical Unit. In P. Joyce, G. Nicholls, K. Thomas & T. Wilkinson (Eds.), The Christchurch experience: 40 years of research and teaching. (pp. 113-116). Christchurch, New Zealand: University of Otago.

Rademaker, M. T., & Espiner, E. (2010). Hormones of the cardiovascular system. In J. L. Jameson & L. J. De Groot (Eds.), Endocrinology: Adult and pediatric (Vol. II). (6th ed.) (pp. 2036-2052). Philadelphia, PA: Saunders.

Rademaker, M. T., & Espiner, E. A. (2006). Hormones of the cardiovascular system. In L. J. DeGroot & J. L. Jameson (Eds.), Endocrinology (Vol. 3). (5th ed.) (pp. 2549-2566). Philadelphia: Elsevier Saunders.

^ Top of page

Journal - Research Article

Madhavan, S., Prickett, T. C. R., Espiner, E. A., & Barrell, G. K. (2017). Nutrient restriction in early ovine pregnancy stimulates C-type natriuretic peptide production. Reproduction, Fertility & Development, 29(3), 575-584. doi: 10.1071/RD15192

Prickett, T. C. R., Doughty, R. N., Troughton, R. W., Frampton, C. M., Whalley, G. A., Ellis, C. J., Espiner, E. A., & Richards, A. M. (2017). C-type natriuretic peptides in coronary disease. Clinical Chemistry, 63(1), 316-324. doi: 10.1373/clinchem.2016.257816

Woodward, Z., Prickett, T. C. R., Espiner, E. A., & Anderson, T. J. (2017). Central and systemic C-type Natriuretic Peptide are both reduced in Parkinson's Disease. Parkinsonism & Related Disorders. Advance online publication. doi: 10.1016/j.parkreldis.2017.06.019

Wilson, M. O., McNeill, B. A., Barrell, G. K., Prickett, T. C. R., & Espiner, E. A. (2017). Dexamethasone increases production of C-type natriuretic peptide in the sheep brain. Journal of Endocrinology. Advance online publication. doi: 10.1530/joe-17-0148

Olney, R. C., Salehi, P., Prickett, T. C. R., Lima, J. J., Espiner, E. A., Sikes, K. M., & Geffner, M. E. (2016). Dynamic response of C-type natriuretic peptide and its aminoterminal propeptide (NTproCNP) to growth hormone treatment in children with short stature. Clinical Endocrinology, 85(4), 561-568. doi: 10.1111/cen.13103

Olney, R. C., Prickett, T. C. R., Espiner, E. A., Mackenzie, W. G., Duker, A. L., Ditro, C., … Bober, M. B. (2015). C-type natriuretic peptide plasma levels are elevated in subjects with achondroplasia, hypochondroplasia, and thanatophoric dysplasia. Journal of Clinical Endocrinology & Metabolism, 100(2), E355-E359. doi: 10.1210/jc.2014-2814

Espiner, E. A., Prickett, T. C. R., Taylor, R. S., Reid, R. A., & McCowan, L. M. (2015). Effects of pre-eclampsia and fetal growth restriction on C-type natriuretic peptide. BJOG, 122(9), 1236-1243. doi: 10.1111/1471-0528.13397

Wilson, M. O., Barrell, G. K., Prickett, T. C. R., & Espiner, E. A. (2015). Sustained increases in plasma C-type natriuretic peptides fail to increase concentrations in cerebrospinal fluid: Evidence from pregnant sheep. Peptides, 69, 103-108. doi: 10.1016/j.peptides.2015.04.016

Prickett, T. C. R., Wellby, M., Barrell, G. K., Richards, A. M., & Espiner, E. A. (2014). Differential response of C-type natriuretic peptide to estrogen and dexamethasone in adult bone. Steroids, 87, 1-5. doi: 10.1016/j.steroids.2014.05.007

Espiner, E. A., Dalrymple-Alford, J. C., Prickett, T. C. R., Alamri, Y., & Anderson, T. J. (2014). C-type natriuretic peptide in Parkinson's disease: Reduced secretion and response to deprenyl. Journal of Neural Transmission, 121(4), 371-378. doi: 10.1007/s00702-013-1123-9

Reid, R. A., Prickett, T. C. R., Pullar, B. E., Darlow, B. A., Gullam, J. E., & Espiner, E. A. (2014). C-type natriuretic peptide in complicated pregnancy: Increased secretion precedes adverse events. Journal of Clinical Endocrinology & Metabolism, 99(4), 1470-1478. doi: 10.1210/jc.2013-3758

Prickett, T. C. R., Hector-Taylor, J., Olney, R. C., Darlow, B. A., & Espiner, E. A. (2013). Acute inflammation in young children inhibits C-type natriuretic peptide. Pediatric Research, 74(2), 191-195. doi: 10.1038/pr.2013.92

Prickett, T. C. R., Olney, R. C., Cameron, V. A., Ellis, M. J., Richards, A. M., & Espiner, E. A. (2013). Impact of age, phenotype and cardio-renal function on plasma C-type and B-type natriuretic peptide forms in an adult population. Clinical Endocrinology, 78(5), 783-789. doi: 10.1111/cen.12035

Hannema, S. E., Duyvenvoorde, H. A., Premsler, T., Yang, R.-B., Mueller, T. D., Gassner, B., … Prickett, T., … Espiner, E. A., … Wit, J. M. (2013). An activating mutation in the kinase homology domain of the natriuretic peptide receptor-2 causes extremely tall stature without skeletal deformities. Journal of Clinical Endocrinology & Metabolism, 98(12), E1988-E1998. doi: 10.1210/jc.2013-2358

Olney, R. C., Prickett, T. C. R., Espiner, E. A., & Ross, J. L. (2012). C-Type natriuretic peptide (CNP) levels are altered in boys with Klinefelter syndrome. Journal of Clinical Endocrinology & Metabolism, 97(11), 4206-4211. doi: 10.1210/jc.2012-2598

Schouten, B. J., Prickett, T. C., Hunt, P. J., Richards, A. M., Geffner, M. E., Olney, R. C., & Espiner, E. A. (2012). C-type natriuretic peptide forms in adult hyperthyroidism: Correlation with thyroid hormones and markers of bone turnover. Clinical Endocrinology, 76(6), 790-796. doi: 10.1111/j.1365-2265.2011.04295.x

Reh, C. S., Olney, R. C., Azen, C., Prickett, T. C., Espiner, E. A., & Geffner, M. E. (2012). Plasma C-type natriuretic peptide forms and thyroid status in prepubertal children with acquired thyroid disease. Clinical Endocrinology, 76(2), 228-235. doi: 10.1111/j.1365-2265.2011.04187.x

Prickett, T. C. R., Lyver, A., Wilson, R., Espiner, E. A., & Sullivan, M. J. (2012). C-type natriuretic peptide: A novel biomarker of steroid induced bone toxicity in children with acute lymphoblastic leukemia (ALL). Peptides, 36(1), 54-59. doi: 10.1016/j.peptides.2012.04.017

Olney, R. C., Permuy, J. W., Prickett, T. C. R., Han, J. C., & Espiner, E. A. (2012). Amino-terminal propeptide of C-type natriuretic peptide (NTproCNP) predicts height velocity in healthy children. Clinical Endocrinology, 77(3), 416-422. doi: 10.1111/j.1365-2265.2012.04392.x

McNeill, B. A., Barrell, G. K., Ridgway, M. J., Wellby, M. P., Prickett, T. C. R., & Espiner, E. A. (2012). Caloric restriction, but not caloric loading, affects circulating fetal and maternal C-type natriuretic peptide concentrations in late ovine gestation. Reproduction, Fertility & Development, 24(8), 1063-1070. doi: 10.1071/rd11312

McNeill, B. A., Barrell, G. K., Wooding, F. B. P., Prickett, T. C. R., & Espiner, E. A. (2011). The trophoblast binucleate cell is the source of maternal circulating C-type natriuretic peptide during ovine pregnancy. Placenta, 32(9), 645-650. doi: 10.1016/j.placenta.2011.06.001

Schouten, B. J., Prickett, T. C. R., Hooper, A. A., Hooper, G. J., Yandle, T. G., Richards, A. M., & Espiner, E. A. (2011). Central and peripheral forms of C-type natriuretic peptide (CNP): Evidence for differential regulation in plasma and cerebrospinal fluid. Peptides, 32(4), 797-804. doi: 10.1016/j.peptides.2011.01.013

Prickett, T. C. R., Bothwell, J. C., Yandle, T. G., Richards, A. M., & Espiner, E. A. (2011). Pharmacodynamic responses of plasma and tissue C-type natriuretic peptide to GH: Correlation with linear growth in GH-deficient rats. Journal of Endocrinology, 15, 217-225. doi: 10.1530/joe-11-0387

Prickett, T. C. R., Ryan, J. F., Wellby, M., Barrell, G. K., Yandle, T. G., Richards, A. M., & Espiner, E. A. (2010). Effect of nutrition on plasma C-type natriuretic peptide forms in adult sheep: Evidence for enhanced C-type natriuretic peptide degradation during caloric restriction. Metabolism, 59(6), 796-801. doi: 10.1016/j.metabol.2009.09.026

Prickett, T. C. R., McNeill, B. A., Oliver, M. H., Harding, J. E., & Espiner, E. A. (2010). Effect of cortisol on C-type natriuretic peptide in ovine pregnancy: Differential responses in fetal and placental tissues. Pediatric Research, 68(6), 462-465. doi: 10.1203/PDR.0b013e3181f9039d

McNeill, B. A., Barrell, G. K., Wellby, M., Prickett, T. C. R., Yandle, T. G., & Espiner, E. A. (2009). C-type natriuretic peptide forms in pregnancy: Maternal plasma profiles during ovine gestation correlate with placental and fetal maturation. Endocrinology, 150(10), 4777-4783. doi: 10.1210/en.2009-0176

Palmer, S. C., Prickett, T. C. R., Espiner, E. A., Yandle, T. G., & Richards, A. M. (2009). Regional release and clearance of C-type natriuretic peptides in the human circulation and relation to cardiac function. Hypertension, 54(3), 612-618. doi: 10.1161/HYPERTENSIONAHA.109.135608

Prickett, T. C. R., Charles, C. J., Yandle, T. G., Richards, A. M., & Espiner, E. A. (2009). Skeletal contributions to plasma CNP forms: Evidence from regional sampling in growing lambs. Peptides, 30(12), 2343-2347. doi: 10.1016/j.peptides.2009.07.023

Prickett, T. C. R., Barrell, G. K., Wellby, M., Yandle, T. G., Richards, A. M., & Espiner, E. A. (2008). Effect of sex steroids on plasma C-type natriuretic peptide forms: Stimulation by oestradiol in lambs and adult sheep. Journal of Endocrinology, 199(3), 481-487. doi: 10.1677/JOE-08-0267

Prickett, T. C. R., Dixon, B., Frampton, C., Yandle, T. G., Richards, A. M., Espiner, E. A., & Darlow, B. A. (2008). Plasma amino-terminal pro C-type natriuretic peptide in the neonate: Relation to gestational age and postnatal linear growth. Journal of Clinical Endocrinology & Metabolism, 93(1), 225-232. doi: 10.1210/jc.2007-1815

Prickett, T. C. R., Barrell, G. K., Wellby, M., Yandle, T. G., Richards, A. M., & Espiner, E. A. (2007). Response of plasma CNP forms to acute anabolic and catabolic interventions in growing lambs. American Journal of Physiology: Endocrinology & Metabolism, 292, E1395-E1400. doi: 10.1152/ajpendo.00469.2006

Prickett, T. C. R., Rumball, C. W. H., Buckley, A. J., Bloomfield, F. H., Yandle, T. G., Harding, J. E., & Espiner, E. A. (2007). C-type natriuretic peptide forms in the ovine fetal and maternal circulations: Evidence for independent regulation and reciprocal response to undernutrition. Endocrinology, 148(8), 4015-4022.

Olney, R. C., Prickett, T. C. R., Yandle, T. G., Espiner, E. A., Han, J. C., & Mauras, N. (2007). Amino-terminal propeptide of C-type natriuretic peptide and linear growth in children: Effects of puberty, testosterone, and growth hormone. Journal of Clinical Endocrinology & Metabolism, 92(11), 4294-4298. doi: 10.1210/jc.2007-0567

Charles, C. J., Prickett, T. C. R., Espiner, E. A., Rademaker, M. T., Richards, A. M., & Yandle, T. G. (2006). Regional sampling and the effects of experimental heart failure in sheep: Differential responses in A, B and C-type natriuretic peptides. Peptides, 27(1), 62-68. doi: 10.1016/j.peptides.2005.06.019

Olney, R. C., Bükülmez, H., Bartels, C. F., Prickett, T. C. R., Espiner, E. A., Potter, L. R., & Warman, M. L. (2006). Heterozygous mutations in natriuretic peptide receptor-B (NPR2) are associated with short stature. Journal of Clinical Endocrinology & Metabolism, 91(4), 1229-1232.

Richards, M., Nicholls, M. G., Espiner, E. A., Lainchbury, J. G., Troughton, R. W., Elliott, J., Frampton, C. M., Crozier, I. G., Yandle, T. G., … for the Christchurch Cardioendocrine Research Group and the Australia-New Zealand Heart Failure Group. (2006). Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease. JACC, 47(1), 52-60. doi: 10.1016/j.jacc.2005.06.085

Prickett, T. C. R., Lynn, A. M., Barrell, G. K., Darlow, B. A., Cameron, V. A., Espiner, E. A., Richards, A. M., & Yandle, T. G. (2005). Amino-terminal proCNP: A putative marker of cartilage activity in postnatal growth. Pediatric Research, 58(2), 334-340.

Rademaker, M. T., Charles, C. J., Espiner, E. A., Frampton, C. M., Lainchbury, J. G., & Richards, A. M. (2005). Four-day urocortin-I administration has sustained beneficial haemodynamic, hormonal, and renal effects in experimental heart failure. European Heart Journal, 26, 2055-2062. doi: 10.1093/eurheartj/ehi351

Rademaker, M. T., Charles, C. J., Espiner, E. A., Frampton, C. M., Lainchbury, J. G., & Richards, A. M. (2005). Endogenous urocortins reduce vascular tone and renin-aldosterone / endothelin activity in experimental heart failure. European Heart Journal, 26(19), 2046-2054. doi: 10.1093/eurheartj/ehi227

Richards, A. M., Lainchbury, J. G., Troughton, R. W., Espiner, E. A., & Nicholls, M. G. (2004). Clinical applications of B-type natriuretic peptides. Trends in Endocrinology & Metabolism, 15(4), 170-174.

More publications...